Published in Schizophr Res on September 01, 2005
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
First aid recommendations for psychosis: using the Delphi method to gain consensus between mental health consumers, carers, and clinicians. Schizophr Bull (2007) 2.09
Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull (2008) 1.44
Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull (2010) 1.23
Negative cognition, depressed mood, and paranoia: a longitudinal pathway analysis using structural equation modeling. Schizophr Bull (2011) 1.20
The phenomenological critique and self-disturbance: implications for ultra-high risk ("prodrome") research. Schizophr Bull (2007) 1.16
Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. Clin Schizophr Relat Psychoses (2010) 1.06
Predicting the occurrence, conviction, distress, and disruption of different delusional experiences in the daily life of people with schizophrenia. Schizophr Bull (2011) 1.06
Failure of neural responses to safety cues in schizophrenia. Arch Gen Psychiatry (2012) 0.99
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci (2010) 0.98
Reappraisal of the interplay between psychosis and depression symptoms in the pathogenesis of psychotic syndromes: results from a twenty-year prospective community study. Eur Arch Psychiatry Clin Neurosci (2010) 0.96
Early detection of schizophrenia: current evidence and future perspectives. World Psychiatry (2006) 0.94
Hypothesis: grandiosity and guilt cause paranoia; paranoid schizophrenia is a psychotic mood disorder; a review. Schizophr Bull (2007) 0.91
Diagnosis and course of affective psychoses: was Kraepelin right? Eur Arch Psychiatry Clin Neurosci (2008) 0.91
3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. Int J Neuropsychopharmacol (2011) 0.89
Evidence for separate diseases?: Stages of one disease or different combinations of symptom dimensions? Eur Arch Psychiatry Clin Neurosci (2008) 0.87
Approaches for unraveling the joint genetic determinants of schizophrenia and bipolar disorder. Schizophr Bull (2008) 0.86
Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics. World J Psychiatry (2016) 0.84
Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers. Brain (2015) 0.82
Comorbid depressive symptoms in the developmental course of adolescent-onset psychosis. Early Interv Psychiatry (2007) 0.82
Psychiatric comorbidities in patients with major depressive disorder. Neuropsychiatr Dis Treat (2014) 0.81
Structural differences within negative and depressive syndrome dimensions in schizophrenia, organic brain disease, and major depression: A confirmatory factor analysis of the positive and negative syndrome scale. Psychopathology (2009) 0.80
Forms of antipsychotic therapy: improved individual outcomes under personalised treatment of schizophrenia focused on depression. EPMA J (2011) 0.80
Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. Front Psychiatry (2015) 0.79
A Longitudinal Examination of the Moderating Effects of Symptoms on the Relationship between Functional Competence and Real World Functional Performance in Schizophrenia. Schizophr Res Cogn (2014) 0.78
Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder. Ann Gen Psychiatry (2011) 0.77
Study of Relationship Between Depression and Quality of Life in Patients With Chronic Schizophrenia. Glob J Health Sci (2015) 0.77
Similarities and differences of functional connectivity in drug-naïve, first-episode adolescent and young adult with major depressive disorder and schizophrenia. Sci Rep (2017) 0.75
Longitudinal investigation of the relationship between family history of psychosis and affective disorders and Child Behavior Checklist ratings in clinical high-risk adolescents. Schizophr Res (2015) 0.75
Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia. PLoS One (2016) 0.75
Agomelatine for Depression in Schizophrenia: A Case-Series. Psychopharmacol Bull (2012) 0.75
Comorbid Moderate-Severe Depressive Symptoms and their Association with Quality of Life in Chinese Patients with Schizophrenia Treated in Primary Care. Community Ment Health J (2016) 0.75
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation (2013) 3.44
Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem (2005) 3.06
Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids. Pain (2009) 1.74
Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury. J Cardiovasc Electrophysiol (2007) 1.73
The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus. Nat Med (2012) 1.72
Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens. J Rheumatol (2004) 1.58
Predictors of treatment in acute coronary syndromes in the elderly: impact on decision making and clinical outcome after interventional versus conservative treatment. Catheter Cardiovasc Interv (2012) 1.53
Microcircuits of functionally identified neurons in the rat medial entorhinal cortex. Neuron (2011) 1.51
Rescue-stenting of an occluded lateral coronary sinus branch for recanalization after dissection during cardiac resynchronization device implantation. Europace (2008) 1.38
Vaccine immunogenicity in injecting drug users. Lancet Infect Dis (2009) 1.37
Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci (2004) 1.34
The septation apparatus, an autonomous system in budding yeast. Mol Biol Cell (2002) 1.26
Morphology of far-field electrograms and antitachycardia pacing effectiveness among fast ventricular tachycardias occurring in ICD patients: the role of other discriminators. J Cardiovasc Electrophysiol (2014) 1.08
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol (2012) 1.07
The early course of schizophrenia and depression*. Eur Arch Psychiatry Clin Neurosci (2005) 1.07
Magnet application in ICD patients. Pacing Clin Electrophysiol (2014) 1.07
Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res (2002) 1.06
Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol (2003) 1.03
Modeling the early course of schizophrenia. Schizophr Bull (2003) 1.02
Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system. Int J Cardiol (2011) 0.99
Myocardium: dynamic versus single-shot CT perfusion imaging. Radiology (2013) 0.99
Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism. Structure (2002) 0.98
Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs. Yeast (2006) 0.97
Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. J Antimicrob Chemother (2008) 0.96
Pulmonary vein electrophysiology during cryoballoon ablation as a predictor for procedural success. J Interv Card Electrophysiol (2011) 0.95
A control study to evaluate a computer-based microarray experiment design recommendation system for gene-regulation pathways discovery. J Biomed Inform (2005) 0.94
Early detection of schizophrenia: current evidence and future perspectives. World Psychiatry (2006) 0.94
Low frequency of deafness-associated GJB2 variants in Kenya and Sudan and novel GJB2 variants. Hum Mutat (2004) 0.93
Comparison of the first and second cryoballoon: high-volume single-center safety and efficacy analysis. Circ Arrhythm Electrophysiol (2014) 0.93
Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy. Pacing Clin Electrophysiol (2009) 0.92
Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2005) 0.92
Raman-spectroscopy-based noninvasive microanalysis of native lignin structure. Anal Bioanal Chem (2011) 0.92
Friction-based stabilization of juxtacellular recordings in freely moving rats. J Neurophysiol (2012) 0.91
A microflow cytometer exploited for the immunological differentiation of leukocytes. Cytometry A (2011) 0.91
Three-dimensional reconstruction allows accurate quantification and length measurements of coronary artery stenoses. EuroIntervention (2009) 0.91
LIM-only protein 4 interacts directly with the repulsive guidance molecule A receptor Neogenin. J Neurochem (2008) 0.90
In situ FT-IR microscopic study on enzymatic treatment of poplar wood cross-sections. Biomacromolecules (2008) 0.90
Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades. Neuropharmacology (2012) 0.89
Inhibitors of GlyT1 affect glycine transport via discrete binding sites. Mol Pharmacol (2008) 0.88
Microflow cytometers with integrated hydrodynamic focusing. Sensors (Basel) (2013) 0.88
Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol (2002) 0.88
Two-dimensional analysis of myocardial protein expression following myocardial ischemia and reperfusion in rabbits. Proteomics (2002) 0.87
Nanosurfaces and nanostructures for artificial orthopedic implants. Nanomedicine (Lond) (2007) 0.87
Evidence for separate diseases?: Stages of one disease or different combinations of symptom dimensions? Eur Arch Psychiatry Clin Neurosci (2008) 0.87
A double-blind, randomized, placebo/active controlled crossover evaluation of the efficacy and safety of Ritalin ® LA in children with attention-deficit/hyperactivity disorder in a laboratory classroom setting. J Child Adolesc Psychopharmacol (2010) 0.87
Chitin synthase III activity, but not the chitin ring, is required for remedial septa formation in budding yeast. FEMS Microbiol Lett (2003) 0.86
Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target. Ann Rheum Dis (2010) 0.86
Preliminary evidence for altered motion tracking-based hyperactivity in ADHD siblings. Behav Brain Funct (2014) 0.86
Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs. Bioorg Med Chem Lett (2005) 0.85
Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2013) 0.84
Melting of sodium clusters: where do the magic numbers come from? Phys Rev Lett (2005) 0.84
Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition. J Cardiovasc Pharmacol (2008) 0.84
Characterization of the neuronal dopamine transporter DAT in human blood platelets. Neurosci Lett (2006) 0.83
Blind image analysis for the compositional and structural characterization of plant cell walls. Anal Chim Acta (2011) 0.82
Disease burden of rotavirus gastroenteritis in children up to 5 years of age in two Swiss cantons: paediatrician- and hospital-based surveillance. Eur J Pediatr (2009) 0.81
Proteome analysis of myocardial tissue following ischemia and reperfusion--effects of complement inhibition. Biochim Biophys Acta (2006) 0.81
Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosis. Cell Rep (2015) 0.81
Stimulation of lipogenesis in rat adipocytes by ATP, a ligand for P2-receptors. Biochem Biophys Res Commun (2004) 0.79
Implantation of cardiac rhythm devices during concomitant anticoagulation or antiplatelet therapy. Expert Rev Cardiovasc Ther (2011) 0.79
Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxiety. Eur J Pharmacol (2006) 0.79
Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol (2010) 0.79
Catheter ablation of ventricular tachycardia in structurally normal hearts. Expert Rev Cardiovasc Ther (2010) 0.78
Prodromal unfolding: the validation of the Schizotypic Syndrome Questionnaire model in a sample of first-episode schizophrenic patients. Early Interv Psychiatry (2009) 0.78
Extracellular electron transport-mediated Fe(III) reduction by a community of alkaliphilic bacteria that use flavins as electron shuttles. Appl Environ Microbiol (2013) 0.78
Measuring mechanical pain: the refinement and standardization of pressure pain threshold measurements. Behav Res Methods (2015) 0.78
Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency. Arthritis Rheum (2005) 0.78
Premelting and postmelting in clusters. Phys Rev Lett (2009) 0.78
A new angiographic method to assess coronary flow reserve-validation in humans. Catheter Cardiovasc Interv (2010) 0.76
Boric acid destabilizes the hyphal cytoskeleton and inhibits invasive growth of Candida albicans. Yeast (2015) 0.76
Ablation strategies for atrial fibrillation. Expert Rev Cardiovasc Ther (2009) 0.76
Esophageal acid levels after pulmonary vein isolation for atrial fibrillation. Pacing Clin Electrophysiol (2009) 0.75
Atrial fibrillation ablation in systolic heart failure patients: a promising tool? Europace (2010) 0.75
Altered expression of 11beta-hydroxysteroid dehydrogenases in rheumatoid arthritis synovial cells: comment on the article by Haas et al. Arthritis Rheum (2007) 0.75
Aromatase activity induction in human adipose fibroblasts by retinoic acids via retinoic acid receptor α. J Mol Endocrinol (2013) 0.75
Psychic skin: psychotic defences, borderline process and delusions. J Anal Psychol (2012) 0.75
Biodegradability testing of synthetic ester lubricants--effects of additives and usage. Chemosphere (2002) 0.75
Mass spectrometric comparison of N-glycan profiles from Caenorhabditis elegans mutant embryos. Glycoconj J (2012) 0.75
Cardio-respiratory exercise testing early after the use of the Angio-Seal system for arterial puncture site closure after coronary angioplasty. EuroIntervention (2011) 0.75
Detection of bis(sulfosuccinimidyl) suberate binding in electrophoresis: determination of membrane sidedness of proteins. Electrophoresis (2007) 0.75
Adsorption of small molecules on silver clusters. J Chem Phys (2012) 0.75
Extrahepatic biliary atresia in a 4-week-old Pug. Vet Surg (2014) 0.75
[Developmental conditions and subjective experiences of children with a schizophrenic parent--qualitative and quantitative studies from the Mannheim Study of Children at Risk]. Psychiatr Prax (2006) 0.75
[Pharmaceutical treatment of atrial fibrillation]. Herzschrittmacherther Elektrophysiol (2008) 0.75
An offline-addition format for identifying GPCR modulators by screening 384-well mixed compounds in the FLIPR. J Biomol Screen (2005) 0.75
Individuation: finding oneself in analysis--taking risks and making sacrifices. J Anal Psychol (2005) 0.75
Imaging modalities in cardiac electrophysiology. Future Cardiol (2010) 0.75
States of grace: Eureka moments and the recognition of the unthought known. J Anal Psychol (2015) 0.75